Rickey James Paul
- SEC CIK
- 0001606243
In the past year, 1 open-market purchase filing worth $500.0K and no sales.
Current role at each company
- BRVE Braveheart Bio, Inc.Chief Financial Officeras of Aug 7, 2026
- ALPN Alpine Immune Sciences, Inc.See Remarksas of May 20, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $500.0K
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$500.0K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Rickey James Paul as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
BRVE Braveheart Bio, Inc.
Chief Financial Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 7, 2026 (view filing)4:41 PM ET | Aug 7 | Same day | Rickey James PaulChief Financial Officer | PPurchase | +27.8K | $18.00 | +$500.0K | +5.6%520.9K after |
ALPN Alpine Immune Sciences, Inc.
See Remarks7 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 29, 2024 (view filing) | Jan 25-26 | 4 days | Rickey James PaulSee Remarks | SSale | −118.0K | $23.31 | −$2.75M | −100.0%0 after | 3 lots10b5-1 |
| Dec 21, 2023 (view filing) | Dec 19 | 2 days | Rickey James PaulSee Remarks | SSale | −15.2K | $19.21 | −$292.2K | −100.0%0 after | 10b5-1 |
| Dec 18, 2023 (view filing) | Dec 14-18 | 4 days | Rickey James PaulSee Remarks | SSale | −58.8K | $19.07 | −$1.12M | −100.0%0 after | 3 lots10b5-1 |
| Dec 6, 2023 (view filing) | Dec 4-6 | 2 days | Rickey James PaulSee Remarks | SSale | −70.8K | $16.06 | −$1.14M | −100.0%0 after | 3 lots10b5-1 |
| Dec 1, 2023 (view filing) | Nov 30 | 1 day | Rickey James PaulSee Remarks | SSale | −700 | $16.00 | −$11.2K | −100.0%0 after | 10b5-1 |
| Nov 8, 2023 (view filing) | Nov 6 | 2 days | Rickey James PaulSee Remarks | SSale | −18.0K | $16.03 | −$288.6K | −100.0%0 after | 10b5-1 |
| Jan 4, 2022 (view filing) | Dec 31, 2021 | 4 days | Rickey James PaulSenior VP and CFO | SSale | −17.0K | $13.92 | −$236.8K | −70.8%7.01K after |